MediBeacon® Transdermal GFRSystem is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in select academic medical centers began in January 2026.
Research has shown that creatinine-based estimated GFR alone does not identify all forms of kidney dysfunction ... estimating GFR using creatinine and analysing the urine albumin-creatinine ratio.".